Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marinee K Chuah

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Science Translational Medicine|July 19, 2013
Vector decoys trick the immune responseThierry VandenDriessche, Marinee K Chuah
Human Gene Therapy Methods|December 17, 2013
Optimizing delivery and expression of designer nucleases for genome engineeringMarinee K Chuah, Thierry VandenDriessche
Human Gene Therapy|August 11, 2017
Hemophilia Gene Therapy: Ready for Prime Time?Thierry VandenDriessche, Marinee K Chuah
Blood|September 21, 2013
Targeting endothelial cells by gene therapyThierry Vandendriessche, Marinee K Chuah
Human Gene Therapy|September 19, 2017
Transposons: Moving Forward from Preclinical Studies to Clinical TrialsJaitip Tipanee, Thierry VandenDriessche, Marinee K Chuah
Seminars in Thrombosis and Hemostasis|May 1, 2004
Clinical gene transfer studies for hemophilia AMarinee K Chuah, Désiré Collen, Thierry VandenDriessche
Therapeutic Advances in Hematology|November 3, 2025
CRISPR and gene editing technologies for bleeding disordersThierry VandenDriessche, Mathias Janssens, Marinee K Chuah
Human Gene Therapy|June 8, 2012
Recent progress in gene therapy for hemophiliaMarinee K Chuah, Nisha Nair, Thierry VandenDriessche
Cardiovascular Research|August 5, 2015
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationMelvin Y Rincon, Thierry VandenDriessche, Marinee K Chuah
Seminars in Thrombosis and Hemostasis|May 1, 2004
Preclinical gene therapy studies for hemophilia using adenoviral vectorsLieven Thorrez, Thierry VandenDriessche, Désiré Collen, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Science Translational Medicine|July 19, 2013
Vector decoys trick the immune responseThierry VandenDriessche, Marinee K Chuah
Human Gene Therapy Methods|December 17, 2013
Optimizing delivery and expression of designer nucleases for genome engineeringMarinee K Chuah, Thierry VandenDriessche
Human Gene Therapy|August 11, 2017
Hemophilia Gene Therapy: Ready for Prime Time?Thierry VandenDriessche, Marinee K Chuah
Blood|September 21, 2013
Targeting endothelial cells by gene therapyThierry Vandendriessche, Marinee K Chuah
Human Gene Therapy|September 19, 2017
Transposons: Moving Forward from Preclinical Studies to Clinical TrialsJaitip Tipanee, Thierry VandenDriessche, Marinee K Chuah
Seminars in Thrombosis and Hemostasis|May 1, 2004
Clinical gene transfer studies for hemophilia AMarinee K Chuah, Désiré Collen, Thierry VandenDriessche
Therapeutic Advances in Hematology|November 3, 2025
CRISPR and gene editing technologies for bleeding disordersThierry VandenDriessche, Mathias Janssens, Marinee K Chuah
Human Gene Therapy|June 8, 2012
Recent progress in gene therapy for hemophiliaMarinee K Chuah, Nisha Nair, Thierry VandenDriessche
Cardiovascular Research|August 5, 2015
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationMelvin Y Rincon, Thierry VandenDriessche, Marinee K Chuah
Seminars in Thrombosis and Hemostasis|May 1, 2004
Preclinical gene therapy studies for hemophilia using adenoviral vectorsLieven Thorrez, Thierry VandenDriessche, Désiré Collen, et al.
Pageof 4